Deepak Nitrite Limited (DEEPAKNTR.NS)
Vadodara, GU, IN
Incorporated in 1970 and headquartered in Vadodara, India, Deepak Nitrite Limited operates as a prominent manufacturer and seller of a diverse portfolio of chemicals. Its offerings span basic, fine, and specialty chemicals, as well as performance products and phenolics. These chemicals are crucial intermediates and raw materials, supporting various sectors such as colorants, dyes, pigments, rubber chemicals, explosives, agrochemicals, pharmaceuticals, food colorants, and fuel additives. Additionally, it provides optical brighteners and specialized products for the paper, detergent, coating, textile, and personal wellness industries. Its phenolics segment features essential compounds like phenol, cumene, isopropyl alcohol, and acetone. With a global reach, the company exports extensively to major regions including Europe, the United States, Japan, Latin America, the Middle East, and the Far East.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.39% | -2.70% | +17.98% | +9.91% | +4.88% | +4.79% | -14.34% | -8.02% | +5.59% | +2,317.99% | +10,135.19% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 4 | 0 |
| Hold | 4 | -1 |
| Sell | 3 | 0 |
| Strong Sell | 4 | 0 |
-
Revenue growth Chemicals: +4.0%-3.8% Q1'26: +3.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-21.0% Q1'26: +8.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+1.7% Q1'26: -22.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+8.4% ★ Q1'26: +11.9% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.8% ★ Q1'26: +10.2% (vs Q1'25)
-
Share dilution Chemicals: +0.0%0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.86× Q1'26: 1.33× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 18 Rev. Ana. 19 EPS Ana. |
Mar 2027 17 Rev. Ana. 19 EPS Ana. |
Mar 2028 16 Rev. Ana. 18 EPS Ana. |
Mar 2029 11 Rev. Ana. 10 EPS Ana. |
Mar 2030 11 Rev. Ana. 8 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
13.17B
est: 13.44B (-2.0%)
|
13.64B
est: 13.66B (-0.1%)
|
13.54B
est: 12.67B (+6.9%)
|
16.11B
est: 15.60B (+3.2%)
|
26.75B
est: 24.79B (+7.9%)
|
41.93B
est: 40.75B (+2.9%)
|
43.33B
est: 41.04B (+5.6%)
|
67.73B
est: 64.66B (+4.8%)
|
78.83B
est: 79.79B (-1.2%)
|
76.10B
est: 76.47B (-0.5%)
|
80.91B
est: 81.01B (-0.1%)
|
78.30B
74.42B – 81.40B
-3.3% YoY
|
89.70B
83.31B – 100.12B
+14.6% YoY
|
101.06B
93.54B – 114.17B
+12.7% YoY
|
138.46B
128.37B – 155.54B
+37.0% YoY
|
152.57B
141.45B – 171.39B
+10.2% YoY
|
| EBITDA |
1.34B
est: 2.73B (-50.9%)
|
1.58B
est: 2.78B (-43.2%)
|
2.13B
est: 748.11M (+185.1%)
|
2.05B
est: 1.73B (+18.1%)
|
4.21B
est: 2.19B (+92.2%)
|
10.59B
est: 4.11B (+157.4%)
|
12.68B
est: 7.76B (+63.4%)
|
16.46B
est: 8.97B (+83.5%)
|
13.37B
est: 8.78B (+52.3%)
|
12.79B
est: 9.26B (+38.1%)
|
11.76B
est: 9.82B (+19.7%)
|
15.95B
15.16B – 16.58B
+62.4% YoY
|
18.28B
16.98B – 20.40B
+14.6% YoY
|
20.59B
19.06B – 23.26B
+12.7% YoY
|
28.21B
26.16B – 31.69B
+37.0% YoY
|
31.09B
28.82B – 34.92B
+10.2% YoY
|
| EBIT |
980.33M
est: 2.39B (-59.0%)
|
1.18B
est: 2.43B (-51.3%)
|
1.65B
est: 1.02B (+61.7%)
|
1.52B
est: 981.72M (+54.9%)
|
3.43B
est: 2.59B (+32.4%)
|
9.19B
est: 5.51B (+66.9%)
|
11.16B
est: 8.27B (+35.0%)
|
14.68B
est: 9.56B (+53.7%)
|
11.71B
est: 9.35B (+25.2%)
|
11.14B
est: 9.86B (+12.9%)
|
9.80B
est: 14.40B (-31.9%)
|
13.94B
13.25B – 14.49B
-3.2% YoY
|
15.97B
14.83B – 17.83B
+14.6% YoY
|
17.99B
16.66B – 20.33B
+12.7% YoY
|
24.65B
22.86B – 27.70B
+37.0% YoY
|
27.17B
25.19B – 30.52B
+10.2% YoY
|
| Net Income |
529.03M
est: 690.32M (-23.4%)
|
627.31M
est: 832.20M (-24.6%)
|
963.15M
est: 544.40M (+76.9%)
|
790.16M
est: 1.05B (-25.1%)
|
1.74B
est: 1.37B (+26.6%)
|
6.11B
est: 2.76B (+121.3%)
|
7.76B
est: 5.66B (+37.1%)
|
10.67B
est: 6.54B (+63.1%)
|
8.52B
est: 6.40B (+33.1%)
|
8.11B
est: 6.75B (+20.1%)
|
6.97B
est: 6.36B (+9.7%)
|
5.11B
4.17B – 5.79B
-19.5% YoY
|
7.36B
3.71B – 8.65B
+43.8% YoY
|
8.65B
5.71B – 10.99B
+17.5% YoY
|
14.84B
13.43B – 17.22B
+71.6% YoY
|
20.75B
18.78B – 24.07B
+39.8% YoY
|
| SGA |
1.01B
est: 591.79M (+71.0%)
|
1.21B
est: 601.60M (+101.9%)
|
1.27B
est: 1.99B (-36.2%)
|
1.39B
est: 2.86B (-51.6%)
|
1.94B
est: 4.62B (-58.0%)
|
2.21B
est: 6.23B (-64.6%)
|
2.51B
est: 4.68B (-46.4%)
|
2.77B
est: 5.41B (-48.7%)
|
3.24B
est: 5.29B (-38.8%)
|
3.60B
est: 5.58B (-35.5%)
|
4.03B
est: 3.84B (+5.2%)
|
3.71B
3.53B – 3.86B
-3.2% YoY
|
4.25B
3.95B – 4.75B
+14.6% YoY
|
4.79B
4.44B – 5.41B
+12.7% YoY
|
6.57B
6.09B – 7.38B
+37.0% YoY
|
7.23B
6.71B – 8.13B
+10.2% YoY
|
| EPS |
5.06
est: 5.06 (+0.0%)
|
6.07
est: 6.10 (-0.5%)
|
8.21
est: 7.00 (+17.3%)
|
6.00
est: 6.06 (-1.0%)
|
12.73
est: 11.23 (+13.3%)
|
44.80
est: 44.02 (+1.8%)
|
56.88
est: 52.82 (+7.7%)
|
78.20
est: 79.30 (-1.4%)
|
62.46
est: 62.79 (-0.5%)
|
59.45
est: 59.09 (+0.6%)
|
51.11
est: 46.75 (+9.3%)
|
37.49
30.60 – 42.44
-19.8% YoY
|
53.93
27.20 – 63.44
+43.8% YoY
|
63.39
41.89 – 80.58
+17.5% YoY
|
108.80
98.49 – 126.25
+71.6% YoY
|
152.10
137.69 – 176.49
+39.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Schwab Emerging Markets Equity ETF SCHE | 0.01% | 1.55M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Deepak Chimanlal Mehta | Chairman & MD | 86M | male |
| Sanjay Upadhyay | Director of Finance, Group Chief Financial Officer & Whole-Time Director | 60M | male |
| Maulik Deepak Mehta | Chief Executive Officer & Executive Director | 50M | male |
| Girish R. Satarkar | President of BI & Executive Director | 24M | male |
| Somsekhar Asimkumar Nanda | Chief Financial Officer & Chief Risk Officer | 11M | male |
| Subimat Mondal | Group Chief Human Resource Officer | — | male |
| Jagdeep Amritlal Vyas | Senior General Manager of Accounts & Taxation | — | — |
| K. C. Bahuguna | Chief Information Officer | — | male |
| Subash Dhar | Head of Technology | — | male |
| Arvind Bajpai | Company Secretary & Compliance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DEEPAKNTR.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
